Middle East Implantable Neurostimulation Devices Market Growing from US$ 142.7 Million to US$ 194.1 Million by 2033
The Middle East neurostimulation devices industry is witnessing steady expansion as healthcare providers increasingly adopt advanced neuromodulation technologies for the treatment of chronic pain, epilepsy, Parkinson’s disease, movement disorders, and other neurological conditions. Neurostimulation devices deliver targeted electrical impulses to specific areas of the nervous system,...
0 Commentarii 0 Distribuiri 41 Views